Introduction {#s1}
============

Colon cancer is the second most common cause of death from cancer in the United States \[[@R01], [@R02]\]. The increasing awareness and implementation of screening programs have led to declines in cancer incidence and mortality \[[@R03]-[@R08]\]. However, recent studies have suggested that current screening techniques may be limited in effectively detecting cancers in the entire colon, showing no significant reduction in proximal colon cancer mortality associated with colonoscopy screening \[[@R9]\]. In addition, some studies have suggested that the declines in overall colon cancer incidence are coupled with a shift to more proximal sites of cancer distribution \[[@R10], [@R11]\].

While declines in colon cancer incidence and mortality are promising, subpopulation analyses have suggested that burden of disease remains disproportionately high for certain demographic groups \[[@R12]-[@R16]\]. Whether these differences from barriers to health care access or a combination of genetic and environmental factors resulting in more advanced cancers at presentation is unclear. Knowledge of race/ethnicity-specific patterns in colon cancer epidemiology will help guide future discussions on targeted screening and community educational programs.

In this analysis, race/ethnicity-specific and sex-specific trends in colon cancer incidence and distribution were examined using the National Cancer Institute\'s Surveillance, Epidemiology, and End Results (SEER) cancer registry. This study focused on the patterns of colon cancer distribution by cancer site and stage during a large inclusive study period. Detailed comparisons of colon cancer incidence between demographic groups were correlated with population data to determine variations in burden of disease.

Methods {#s2}
=======

Data sources {#s2a}
------------

Data were obtained from a population-based cancer registry representing approximately 26% of the U.S population \[[@R17]\]. The 1973-2004 population includes data from 17 regions within the following states: Connecticut, Michigan, Hawaii, Iowa, New Mexico, California, Washington, Utah, Georgia, Alaska, Kentucky, Louisiana, and New Jersey \[[@R17], [@R18]\]. Incidence data for expanded race classifications were only available from 1992-2004; thus the incidence comparisons were limited to this interval.

Definitions {#s2b}
-----------

Colon cancer cases were identified using the International Classification of Disease for Oncology, 3rd edition \[[@R19]\]. This study utilized SEER\'s expanded race/ethnicity classifications: non-Hispanic whites, blacks, Asian/Pacific Islanders (Asians), and white Hispanics (Hispanics). Few data from other groups (American Indian/Alaskan Natives, black Hispanics) precluded precise analyses and were not included in this study \[[@R18]\]. SEER also records the anatomic site of cancer distribution. This study used the following site definitions: proximal colon (cecum, appendix, ascending colon, and hepatic flexure), transverse colon, and distal colon (splenic flexure, descending colon, sigmoid colon, rectosigmoid junction, and rectum). Cancer staging definitions were based on SEER staging systems, which are unique to the SEER database and used primarily for describing extent of disease, and not necessarily for prognostic determination \[[@R20]\]. Localized cancers are confined to the colon without transmural invasion to or beyond the serosa. Regional cancers involve spread to regional lymph nodes or direct extension to adjacent tissue. Distant or advanced cancers include metastatic disease and cancers with distant lymph node involvement.

Statistical analysis {#s2c}
--------------------

All analyses were performed using the SEER\*Stat 6.5.3 program (National Cancer Institute, Maryland) and the Stata statistical package (release ten, Stata Corporation, Texas). P-values for comparisons were calculated with the z-statistic using standard equations \[[@R21]\]. Annual incidence rates are per 100,000 and were age-adjusted to the U.S standard population of 2000. Calendar year-specific rates were calculated based on 3-year and 4-year averages depending on the number of years available for inclusion.

Results {#s3}
=======

Overview {#s3a}
--------

Overall, from 1973-2004, over 500,000 cases of colon cancer were identified. Among all groups, the distal colon was the most common site of cancer involvement, and the majority of cancers were localized staged at diagnosis ([Table 1](#T1){ref-type="table"}).

###### Overall colon cancer distribution by site of cancer and stage of cancer at diagnosis, stratified by race/ethnicity, 1973-2004.

                       Distribution by Site                                   
  -------------------- ---------------------- ------- ------- ------ -------- -------
  Non-hispanic white   136139                 32.8%   29509   7.1%   249045   60.1%
  Black                15459                  35.3%   3228    7.4%   25150    57.4%
  Asians               7099                   23.2%   1802    5.9%   21692    70.9%
  Hispanic             7653                   29.9%   1384    5.4%   16541    64.7%

                       Distribution by Stage                                    
  -------------------- ----------------------- ------- -------- ------- ------- -------
  Non-hispanic white   166064                  41.4%   155428   38.7%   79993   19.9%
  Black                15966                   37.8%   15546    36.8%   10732   25.4%
  Asians               12315                   41.4%   11947    40.1%   5509    18.5%
  Hispanic             9811                    39.3%   9774     39.2%   5358    21.5%

The percentages are calculated horizontally across each row and represent the proportion of cancers within each race/ethnic group.

Colon cancer distribution {#s3b}
-------------------------

[Table 1](#T1){ref-type="table"} presents the overall colon cancer distribution by anatomic site and cancer stage from 1973-2004. The greatest proportion of distal cancers was seen among Asians (distal, 70.9%; proximal, 23.2%), and the greatest proportion of proximal cancers was seen among blacks (proximal, 35.3%; distal, 57.4%). Among all race/ethnic groups, localized cancers represented about 40% of colon cancers. The proportion of advanced cancers was greatest among blacks (25.4%) and lowest among Asians (18.5%), p \< 0.0001.

[Figure 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"} show trends in anatomic distribution of colon cancer by 4-year intervals, stratified by sex and race/ethnicity. Among males, all groups demonstrated a gradual shift towards more proximal distributions of colon cancers. The greatest absolute percentage change was seen among non-Hispanic white males (proximal: 22.4% to 32.5%, p \< 0.0001, [Fig. 1](#F1){ref-type="fig"}). Black males also demonstrated a gradual trend towards increased proportion of proximal cancers diagnosed (27.5% to 34.7%, p \< 0.0001) and remained the group with the greatest proportion of proximal cancers for all time periods analyzed.

![Colon cancer distribution by anatomical site and year, 1973-2004. Males, stratified by race/ethnicity.](gr-02-268-g001){#F1}

![Colon cancer distribution by anatomical site and year, 1973-2004. Females, stratified by race/ethnicity.](gr-02-268-g002){#F2}

Similar trends towards increased proximal distributions of cancers were seen among females. The greatest absolute increase in the proportion of proximal cancers was seen among Hispanic females (21.5% to 47.7%, p \< 0.0001, [Fig. 2](#F2){ref-type="fig"}). Sex-specific comparisons demonstrated greater proportions of proximal cancers among females. For example, for the 2001-2004 time period, proximal distributions represented 28.2% of cancers among Hispanic males and 47.7% of cancers among Hispanic females, p \< 0.0001. This sex-specific disparity in proximal cancer distribution was seen among all race/ethnic groups and among the majority of time intervals studied ([Fig. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}).

Colon cancer incidence by anatomic site and cancer stage {#s3c}
--------------------------------------------------------

[Table 2](#T2){ref-type="table"} shows the average incidence rates of colon cancer from 1992-2004, stratified by sex, race/ethnicity, and anatomic site by 3-year intervals, with the exception of the last interval being a 4-year average because of the odd number of years available for analysis. Among both males and females, blacks had the highest rates of both proximal and distal cancers. For example, during the 2001-2004 interval, the incidence rate of proximal cancers among black males was more than double that of Asian males, the group with the lowest rate (25.2 per 100,000/year vs 11.7 per 100,000/year, p \< 0.0001) and the rate of proximal cancers among black females was twice that of Asian females (21.9 per 100,000/year vs 11.4 per 100,000/year, p \< 0.0001).

###### Average colon cancer incidence rates among males and females per 100,000 population/year, stratified by anatomic site, 1992-2004.

                         [1992-94]{.ul}                  [1995-97]{.ul}                 [1998-2000]{.ul}                 [2001-04]{.ul}   
  ---------------------- ---------------- -------------- ---------------- ------------- ------------------ ------------- ---------------- -------------
  **[Males]{.ul}**                                                                                                                        
  **Total Cancers**                                                                                                                       
  Non Hispanic white     68.7 (20211)     (67.7-69.6)    65.9 (2098)      (65.0-66.8)   65.4 (20747)       (64.5-66.3)   58.6 (26075)     (57.9-59.3)
  Black                  75.9 (2232)      (72.6-79.3)    73.2 (2312)      (70.0-76.4)   75.1 (2509)        (72.0-78.2)   72.8 (3589)      (70.3-75.3)
  Asians                 59.3 (1959)      (56.6-62.1)    58.6 (2252)      (56.2-61.2)   56.4 (2493)        (54.2-58.7)   53.0 (3688)      (51.3-54.8)
  Hispanic               48.7 (1456)      (45.8-51.3)    50.0 (1710)      (47.4-52.6)   51.0 (1972)        (48.5-53.5)   46.3 (2976)      (44.5-48.1)
                                                                                                                                          
  **Proximal Cancers**                                                                                                                    
  Non Hispanic white     20.1 (5872)      (19.6-20.7)    20.4 (6080)      (19.8-20.9)   20.3 (6312)        (19.8-20.8)   19.0 (8295)      (18.6-19.4)
  Black                  25.1 (722)       (23.2-27.1)    23.7 (734)       (21.9-25.6)   26.8 (856)         (24.9-28.7)   25.2 (1206)      (23.6-26.8)
  Asians                 12.2 (389)       (10.9-13.5)    12.4 (467)       (11.3-13.6)   12.3 (521)         (11.2-13.4)   11.7 (767)       (10.9-12.6)
  Hispanic               13.8 (381)       (12.3-15.4)    13.9 (460)       (12.5-15.3)   14.4 (514)         (13.1-15.9)   13.0 (791)       (12.1-14.0)
                                                                                                                                          
  **Distal Cancers**                                                                                                                      
  Non Hispanic white     41.7 (12495)     (41.0-42.5)    39.1 (12111)     (38.4-39.8)   38.7 (12446)       (38.0-39.3)   33.8 (15262)     (33.3-34.4)
  Black                  41.8 (1264)      (39.4-44.3)    41.2 (1337)      (38.9-43.6)   39.1 (1368)        (37.0-41.4)   39.1 (1984)      (37.3-40.9)
  Asians                 42.5 (1422)      (40.3-44.9)    41.5 (1615)      (39.5-43.6)   40.2 (1801)        (38.3-42.1)   36.7 (2608)      (35.3-38.2)
  Hispanic               30.8 (961)       (28.7-33.0)    31.9 (1118)      (29.8-34.0)   32.0 (1280)        (30.1-33.9)   29.1 (1927)      (27.8-30.6)
                                                                                                                                          
  **[Females]{.ul}**                                                                                                                      
  **Total Cancers**                                                                                                                       
  Non Hispanic white     48.0 (19970)     (47.3-48.7)    47.4 (20167)     (46.7-48.1)   48.0 (20810)       (47.4-48.7)   43.9 (25899)     (43.4-44.5)
  Black                  57.2 (2460)      (55.0-59.6)    55.9 (2553)      (53.8-58.2)   57.7 (2833)        (55.6-59.8)   54.2 (3879)      (52.5-56.0)
  Asians                 40.9 (1626)      (38.9-43.0)    38.1 (1801)      (36.3-39.9)   39.2 (2193)        (37.5-40.9)   37.8 (3378)      (36.5-39.1)
  Hispanic               33.7 (1358)      (31.9-35.6)    32.4 (1464)      (30.7-34.1)   34.0 (1739)        (32.4-35.7)   31.2 (2582)      (30.0-32.5)
                                                                                                                                          
  **Proximal Cancers**                                                                                                                    
  Non Hispanic white     17.0 (7201)      (16.6-17.4)    17.0 (7429)      (16.6-17.4)   18.1 (8019)        (17.7-18.5)   17.0 (10267)     (16.7-17.4)
  Black                  21.1 (900)       (19.7-22.5)    21.7 (986)       (20.4-23.2)   22.3 (1077)        (21.0-23.7)   21.9 (1544)      (20.5-23.1)
  Asians                 11.2 (424)       (10.2-12.4)    9.6 (440)        (8.7-10.5)    11.1 (605)         (10.2-12.0)   11.4 (999)       (10.7-12.2)
  Hispanic               10.9 (423)       (9.9-12.0)     11.0 (474)       (10.0-12.1)   11.9 (586)         (10.9-12.9)   11.5 (906)       (10.7-12.3)
                                                                                                                                          
  **Distal Cancers**                                                                                                                      
  Non Hispanic white     25.6 (10439)     (25.1-26.1)    24.8 (10301)     (24.3-25.3)   24.7 (10413)       (24.3-25.2)   22.0 (12599)     (21.6-22.4)
  Black                  29.5 (1279)      (27.9-31.2)    27.7 (1271)      (26.2-29.3)   28.3 (1416)        (26.9-29.9)   25.8 (1878)      (24.6-27.0)
  Asians                 25.9 (1063)      (24.3-27.3)    24.6 (1189)      (23.2-26.1)   24.1 (1375)        (22.8-25.4)   23.3 (2110)      (22.3-24.3)
  Hispanic               19.7 (814)       (18.3-21.1.)   17.8 (842)       (16.6-19.1)   18.7 (990)         (17.6-20.0)   16.6 (1432)      (15.8-17.5)

Annual incidence rates are age-standardized to U.S. population of 2000 and are stratified by sex, year, anatomic site, and race/ethnicity. Proximal refers to cancers involving cecum, appendix, ascending colon, and hepatic flexure. Distal refers to cancers involving splenic flexure, descending colon, sigmoid colon, rectosigmoid junction, and rectum. "Total cancers" include proximal, transverse, and distal sites of the colon.

While all groups showed a trend towards decreased incidence of distal colon cancers, the incidence of proximal cancers remained steady for most groups, and even demonstrated a upward trend in some groups ([Table 2](#T2){ref-type="table"}). For example, among black males the incidence of distal cancers decreased from 41.8 per 100,000/year to 39.1 per 100,000/year, p = 0.08, whereas the incidence of proximal cancers among the same group was essentially unchanged (25.1 per 100,000/year to 25.2 per 100,000/year, p = 0.94). Among females, rates of distal cancers demonstrated a downward trend in all race/ethnic groups. However, the rates of proximal cancers among females remained the same or increased in all groups ([Table 2](#T2){ref-type="table"}).

[Table 3](#T3){ref-type="table"} shows the average incidence rates of colon cancer from 1992-2004, stratified by sex, race/ethnicity, and cancer stage using the same time intervals. Among all race/ethnic groups, blacks had one of the highest incidence rates of cancer for all stages. Race/ethnicity-specific comparisons demonstrated significant disparities. For example, during 2001-2004, the rate of advanced cancers among black males was nearly double that of Hispanic males (17.1 per 100,000/year vs 8.7 per 100,000/year, p \< 0.0001) and the rate of advanced cancers among black females was twice that of Hispanic females (12.4 per 100,000/year vs 6.2 per 100,000/year, p \< 0.0001). Race/ethnicity specific disparities among localized cancers were not as robust. For example, from 2001-2004, the rate of localized cancers among black males was 50% greater than Hispanic males (26.3 per 100,000/year vs 17.6 per 100,000/year, p \< 0.0001) and the rate among black females was 60% greater than among Hispanic females (18.3 per 100,000/year vs 12.1 per 100,000/year, p \< 0.0001).

###### Average colon cancer incidence rates among males and females per 100,000 population/year, stratified by cancer stage, 1992-2004.

                          [1992-94]{.ul}                 [1995-97]{.ul}                 [1998-2000]{.ul}                 [2001-04]{.ul}   
  ----------------------- ---------------- ------------- ---------------- ------------- ------------------ ------------- ---------------- -------------
  **[Males]{.ul}**                                                                                                                        
  **Localized Cancers**                                                                                                                   
  Non-hispanic white      27.1 (7992)      (26.5-27.7)   25.8 (7888)      (25.2-26.4)   26.9 (8585)        (26.4-27.5)   25.1 (11184)     (24.7-25.6)
  Black                   26.8 (776)       (24.9-28.9)   26.4 (843)       (24.5-28.3)   26.8 (890)         (25.0-28.7)   26.3 (1292)      (24.8-27.9)
  Asians                  23.9 (787)       (22.2-25.7)   23.9 (922)       (22.3-25.5)   22.9 (1018)        (21.5-24.4)   22.0 (1526)      (20.9-23.1)
  Hispanic                16.9 (516)       (15.3-18.5)   19.5 (659)       (17.9-21.2)   18.8 (725)         (17.3-20.4)   17.6 (1116)      (16.5-18.7)
                                                                                                                                          
  **Regional Cancers**                                                                                                                    
  Non-hispanic white      24.3 (7229)      (23.8-24.9)   23.5 (7198)      (22.9-24.0)   23.6 (7512)        (23.1-24.2)   20.5 (9114)      (20.0-20.9)
  Black                   25.1 (770)       (23.3-27.1)   23.4 (747)       (21.7-25.3)   25.2 (855)         (23.5-27.1)   24.0 (1202)      (22.6-25.5)
  Asians                  21.7 (728)       (20.1-23.4)   21.6 (833)       (20.1-23.1)   21.5 (956)         (20.1-22.9)   18.8 (1315)      (17.8-19.8)
  Hispanic                18.5 (546)       (16.8-20.2)   17.7 (614)       (16.2-19.3)   18.2 (730)         (16.8-19.7)   17.1 (1105)      (16.0-18.2)
                                                                                                                                          
  **Advanced Cancers**                                                                                                                    
  Non-hispanic white      12.7 (3786)      (12.3-13.1)   12.3 (3814)      (11.9-12.7)   11.4 (3657)        (11.0-11.8)   10.4 (4685)      (10.1-10.7)
  Black                   16.7 (506)       (15.2-18.3)   16.6 (528)       (15.1-18.1)   17.5 (594)         (16.1-19.1)   17.1 (873)       (15.9-18.3)
  Asians                  10.1 (344)       (9.0-11.3)    9.7 (377)        (8.7-10.7)    9.2 (415)          (8.4-10.2)    10.0 (706)       (9.3-10.8)
  Hispanic                10.1 (306)       (8.9-11.4)    9.6 (349)        (8.5-10.8)    10.1 (398)         (9.0-11.2)    8.7 (598)        (7.9-9.5)
                                                                                                                                          
  **[Females]{.ul}**                                                                                                                      
  **Localized Cancers**                                                                                                                   
  Non-hispanic white      17.9 (7440)      (17.5-18.3)   17.9 (7576)      (17.5-18.5)   19.2 (8269)        (18.8-19.6)   18.3 (10700)     (17.9-18.6)
  Black                   19.8 (849)       (18.5-21.2)   20.0 (908)       (18.7-21.4)   20.9 (633)         (19.6-22.2)   19.2 (1366)      (18.1-20.2)
  Asians                  14.7 (601)       (13.5-16.0)   15.5 (734)       (14.3-16.6)   14.9 (839)         (13.9-15.9)   14.8 (1328)      (14.0-15.6)
  Hispanic                11.2 (455)       (10.2-12.3)   11.3 (503)       (10.3-12.4)   12.4 (1024)        (11.4-13.4)   12.1 (993)       (11.3-12.8)
                                                                                                                                          
  **Regional Cancers**                                                                                                                    
  Non-hispanic white      18.1 (7495)      (17.7-18.6)   17.7 (7524)      (17.3-18.2)   18.1 (7780)        (17.6-18.5)   15.6 (9180)      (15.3-16.0)
  Black                   19.5 (842)       (18.2-20.9)   19.4 (892)       (18.8-20.7)   19.3 (948)         (18.1-20.6)   18.9 (1347)      (17.9-19.9)
  Asians                  16.5 (654)       (15.2-17.8)   14.1 (672)       (13.1-15.3)   15.8 (884)         (14.7-16.8)   15.0 (1343)      (14.2-15.8)
  Hispanic                13.4 (546)       (12.3-14.6)   12.3 (563)       (11.2-13.3)   12.9 (663)         (11.9-13.9)   10.8 (900)       (10.1-11.5)
                                                                                                                                          
  **Advanced Cancers**                                                                                                                    
  Non-hispanic white      8.9 (3646)       (8.6-9.1)     8.8 (3672)       (8.5-9.0)     8.1 (3448)         (7.8-8.4)     7.8 (4538)       (7.6-8.0)
  Black                   12.5 (552)       (11.4-13.6)   11.9 (549)       (10.9-12.9)   12.8 (639)         (11.8-13.8)   12.4 (903)       (11.6-13.3)
  Asians                  6.3 (257)        (5.5-7.1)     5.9 (292)        (5.3-6.7)     6.6 (376)          (6.0-7.3)     6.5 (588)        (6.0-7.1)
  Hispanic                6.7 (272)        (5.9-7.6)     6.8 (318)        (6.1-7.7)     6.7 (353)          (6.0-7.4)     6.2 (524)        (5.6-6.7)

Annual incidence rates are age-standardized to U.S. population of 2000 and are stratified by sex, year, cancer stage, and race/ethnicity. Localized stages refer to cancers confined to the colon without transmural invasion to or beyond the serosa. Regional stages involve spread to regional lymph nodes or direct extension to adjacent tissue. Advanced cancers include metastatic disease and cancers with distant lymph node involvement.

While cancer rates among non-Hispanic whites and Asians showed a downward trend for all stages, rates among blacks and Hispanics were unchanged. From 1992-1994 to 2001-2004, the rates of localized cancers among Hispanic males (16.9 per 100,000/year to 17.6 per 100,000/year, p = 0.47) and the rates of advanced cancers among black males (16.7 per 100,000/year to 17.1 per 100,000/year, p = 0.69) did not show significant changes ([Table 3](#T3){ref-type="table"}).

Colon cancer incidence using combined stage/site comparisons {#s3d}
------------------------------------------------------------

[Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"} demonstrate that blacks have the highest cancer rates of proximal and advanced cancers. A combined cancer stage/site comparison may help delineate the etiology of these disparities. Table 4 shows the overall average incidence rates of colon cancer from 1992-2004 using a combined cancer stage and anatomic site comparison, stratified by sex and race/ethnicity. Among males and females, blacks had the greatest incidence rate of proximal cancers among both localized and advanced stages. For example, the rate of advanced proximal cancers among black males was more than double that of Asian males (6.0 per 100,000/year vs 2.5 per 100,000/year, p \< 0.001) and the rate of advanced proximal cancers among black females was more than double that of Asian females (5.2 per 100,000/year vs 2.0 per 100,000/year, p \< 0.001). Among distal cancers, the sex-specific disparities were not as robust. For example, the incidence rate of advanced distal cancers among black males was 50% greater than that of Hispanic males (8.5 per 100,000/year vs 5.6 per 100,000/year, p \< 0.001) and the rate of advanced distal cancers among black females was 70% greater than that of Hispanic females (5.4 per 100,000/year vs 3.1 per 100,000/year, p \< 0.001).

###### Average colon cancer incidence rates among males and females per 100,000 population/year, stratified by cancer stage and anatomic site, 1992-2004.

                         [Localized cancers]{.ul}                         [Advanced cancers]{.ul}               
  ---------------------- -------------------------- ------------- ------- ------------------------- ----------- -------
  **[Males]{.ul}**                                                                                              
  **Proximal cancers**                                                                                          
  Non-Hispanic white     7.4 (9763)                 (7.2-7.5)     38.1%   3.9 (5274)                (3.8-4.0)   20.6%
  Black                  8.6 (1167)                 (8.1-9.1)     34.5%   6.0 (871)                 (3.6-6.5)   25.7%
  Asians                 4.4 (773)                  (4.1-4.7)     37.1%   2.5 (443)                 (2.2-2.7)   21.5%
  Hispanic               4.6 (717)                  (4.3-4.9      34.7%   2.7 (448)                 (2.5-3.0)   21.7%
                                                                                                                
  **Distal cancers**                                                                                            
  Non-Hispanic white     17.0 (23515)               (16.8-17.2)   47.1%   6.2 (8610)                (6.0-6.3)   17.2%
  Black                  15.9 (2365)                (15.2-16.6)   42.6%   8.5 (1290)                (8.0-9.0)   23.2%
  Asians                 17.2 (3236)                (16.6-17.8)   45.3%   6.2 (1196)                (5.8-6.6)   16.8%
  Hispanic               12.5 (2137)                (11.9-13.1)   42.5%   5.6 (1020)                (5.3-6.0)   20.3%
                                                                                                                
  **[Females]{.ul}**                                                                                            
  **Proximal cancers**                                                                                          
  Non-Hispanic white     6.3 (12128)                (6.2-6.4)     38.2%   3.3 (6119)                (3.2-3.4)   19.3%
  Black                  7.3 (1492)                 (6.9-7.7)     34.8%   5.2 (1107)                (4.9-5.6)   25.8%
  Asians                 3.7 (835)                  (3.5-4.0)     35.1%   2.0 (469)                 (1.8-2.2)   19.7%
  Hispanic               3.9 (810)                  (3.6-4.2)     35.1%   2.4 (522)                 (2.2-2.6)   22.6%
                                                                                                                
  **Distal cancers**                                                                                            
  Non-Hispanic white     10.7 (19281)               (10.5-10.8)   46.5%   3.9 (6953)                (3.8-4.0)   16.8%
  Black                  11.0 (2336)                (10.6-11.5)   43.0%   5.4 (1152)                (5.1-5.7)   21.2%
  Asians                 10.2 (2430)                (9.8-10.6)    29.6%   3.7 (889)                 (3.5-3.9)   16.2%
  Hispanic               7.2 (1623)                 (6.8-7.5)     42.0%   3.1 (735)                 (2.9-3.4)   19.0%

Annual incidence rates are age-standardized to U.S. population of 2000 and are stratified by sex, cancer stage, anatomic site, and race/ethnicity. Percentages are calculated horizontally across each row and represent the proportion of cancers within each race/ethnic group. The proportion of regional staged cancers are not presented in this table.

Discussion {#s4}
==========

Colon cancer is one of the leading causes of cancer death in the United States \[[@R01], [@R02]\]. Advances in cancer prevention and screening programs have lead to dramatic declines in overall cancer incidence and improvements in cancer survival \[[@R03]-[@R08]\]. The success of colon cancer screening programs can be evaluated by its effects on cancer incidence, survival, and the stage/severity of cancers detected. Recent studies have suggested that colonoscopy screening does not reduce mortality from proximal cancers \[[@R9]\]. Identifying specific cohorts with an increased trend towards proximal distribution of cancers is a first step in targeting disease-specific disparities.

In this study, a steady trend towards an increased proximal distribution of cancers was seen among all groups ([Fig. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). Sex-specific and race/ethnicity-specific comparisons demonstrated that females and blacks had the greatest proportion of proximal cancers ([Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). As a result, blacks and females as a group would benefit most from complete rather than limited screening examinations (e.g. sigmoidoscopy). Furthermore, these data suggest that any targeted approach to address the lack of a survival benefit from current colon cancer screening programs for proximally located cancers should focus on blacks and females.

This study demonstrated striking disparities in sex-specific and race/ethnicity specific incidence rates of colon cancer. Cancer incidence among blacks was one of the highest among both males and females and among all cancer sites and stages ([Tables 2](#T2){ref-type="table"}- 4). Whether these race/ethnicity-specific disparities represent variations in cancer biology or unequal access to health care resources is unclear. A detailed analysis using a combined cancer stage/cancer site comparison may help delineate some of the underlying factors. Current colon cancer screening programs are associated with improved survival from left-sided or distal cancers \[[@R03]-[@R9]\]. The association between cancer screening and right-sided or proximal cancers is less clear \[[@R9]\]. As a result, focusing specifically on the epidemiology of distal cancers may contribute information regarding the etiology of race/ethnicity-specific disparities in cancer incidence. Identifying more advanced distal cancers among certain groups would suggest impaired access to cancer screening programs and not necessarily cancer biology because standard screening examinations would have identified these cancers earlier. In this study, blacks as a group had significantly greater rates of advanced distal cancers. The rates of localized distal cancers were also significantly greater among blacks. The greater rates of advanced distal cancers among blacks likely represent delayed cancer screening, possibly a result of barriers or limitations to timely cancer screening. It is conceivable that genetics and cancer biology may also be different among blacks leading to more aggressive disease at presentation. However, if this were the case, the increased rates of advanced cancers would be seen concurrently with relatively lower rates of localized cancers. In this study, higher cancer incidence was seen for blacks among both localized and advanced stages of distal cancers (Table 4). Limitations in health care access along with race/ethnicity-specific variations in cancer incidence are likely to play important roles in the cancer disparities seen. A targeted cancer screening approach that takes into account the race/ethnicity-specific and sex-specific variations in colon cancer incidence will likely have the greatest benefit.

Disparities among proximal colon cancers is less clear in its implications given recent findings showing no survival benefit from colonoscopy for right-sided or proximal colon cancers \[[@R9]\]. While certain groups being offered alternative screening tests (fecal occult blood, sigmoidoscopy) with poorer sensitivity for detecting proximal tumors may account for the greater proportion of proximal cancers, the study by Baxter, et al. included patients that were all exposed to complete colonoscopy \[[@R9]\]. Current screening techniques may lack sensitivity for detecting proximal colon cancers, leading to more advanced disease at presentation. As a result, sex-specific and race/ethnicity-specific disparities in the incidence of proximal cancers may not necessarily represent variations in access to health care. Identifying a greater incidence of advanced proximal cancers may represent variations in cancer biology. The fact that current screening programs reduce mortality for proximal cancers, and thereby do not affect the natural progression of these cancers suggest that sex-specific or race/ethnicity-specific variations in disease severity among proximal cancers may more likely result from variations in cancer biology. In this study, blacks demonstrated significantly higher rates of advanced proximal cancers among males and females. This finding may represent genetic or biological variations in this group that are race/ethnicity-specific.

While it is known that colon cancer rates are higher and tend to be more aggressive among blacks, unequal access to health care is also well documented among this group \[[@R13], [@R22]-[@R27]\]. The possibility that minority groups have suboptimal access to cancer education and health care resources is undeniable and further interventions to target these under-represented groups are needed. Community programs targeting minority groups and greater awareness among health care professionals should be a major component of any cancer prevention and screening intervention \[[@R27], [@R28]\]. Furthermore, an individualized approach to research and improvements in colon cancer screening guidelines would benefit from incorporating the sex-specific and race/ethnicity-specific disparities observed in this study.

The strengths of this study include the utilization of high quality data from a population-based cancer registry that represents a large proportion of the United States and is globally recognized as an authoritative source of information on cancer incidence and survival in the U.S. \[[@R17], [@R18]\]. A large inclusive study period with detailed data for expanded race/ethnic groups permitted accurate assessment of epidemiological data that is generalizable to the U.S. population.

Our analysis is limited by factors inherent in registry data. The lack of available data on types of colon cancer screening techniques used prevented the analysis of associations between various screening examinations and the disparities observed. The SEER staging system used in this study is not the most effective staging system used in clinical practice and the simplicity of this staging system does not account for the spectrum of disease that exists within each category. However, even if this were the case, it would not fully account for the gender-specific and race/ethnicity-specific disparities this study demonstrates. For the sake of consistency and accuracy of comparisons across all groups and time periods, our study utilized the SEER staging system.

In conclusion, our study describes marked sex-specific and race/ethnicity-specific disparities in colon cancer epidemiology. Significantly higher rates of advanced cancers among blacks and proximal cancers among females may represent disparities in health care access or sex-specific and race/ethnicity-specific variations in cancer biology. Any future attempts to improve cancer prevention and screening programs should focus on interventions to address the disparities seen among these groups. Further research and programs to improve cancer screening would benefit from a targeted approach taking into account these sex-specific and race/ethnicity-specific cancer disparities. More studies are needed to clarify the etiology behind these variations in cancer epidemiology and to determine what effect this has on overall colon cancer survival.
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